P J Blanchet
Overview
Explore the profile of P J Blanchet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paquet F, Bedard M, Levesque M, Tremblay P, Lemay M, Blanchet P, et al.
Exp Brain Res
. 2007 Oct;
185(2):227-36.
PMID: 17957363
Sensorimotor adaptation is thought to involve a remapping of the kinematic and kinetic parameters associated with movements performed within a changing environment. Patients with Parkinson's disease (PD) are known to...
2.
Levesque M, Bedard M, Courtemanche R, Tremblay P, Scherzer P, Blanchet P
Exp Brain Res
. 2007 Jul;
182(4):499-508.
PMID: 17653704
Results obtained in patients with schizophrenia have shown that antipsychotic drugs may induce motor learning deficits correlated with the striatal type-2 dopamine receptors (D(2)R) occupancy. Other findings suggest that the...
3.
Hadj Tahar A, Blanchet P, Doyon J
Behav Pharmacol
. 2005 Mar;
16(2):107-12.
PMID: 15767846
Motor skills, once learned, need to be consolidated over time in order to become resistant to disruption or interference. In some instances, the consolidation phase can also include spontaneous gains...
4.
Blanchet P, Calon F, Morissette M, Goulet M, Grondin R, Levesque D, et al.
Adv Neurol
. 2001 Sep;
86:337-44.
PMID: 11553994
No abstract available.
5.
Lavigne G, Soucy J, Lobbezoo F, Manzini C, Blanchet P, Montplaisir J
Clin Neuropharmacol
. 2001 Jun;
24(3):145-9.
PMID: 11391125
This study was designed to assess the effects of bromocriptine, a dopamine D2 receptor agonist, on sleep bruxism. Seven otherwise healthy patients with severe and frequent sleep bruxism participated in...
6.
Calon F, Lavertu N, Lemieux A, Morissette M, Goulet M, Grondin R, et al.
Synapse
. 2001 Apr;
40(3):225-34.
PMID: 11304760
We investigated the effect of MPTP-induced lesion of the substantia nigra pars compacta (SNpc) dopaminergic neurons on GABA(B) receptors in the basal ganglia of mice and monkeys using receptor autoradiography...
7.
Calon F, Hadj Tahar A, Blanchet P, Morissette M, Grondin R, Goulet M, et al.
Trends Neurosci
. 2000 Oct;
23(10 Suppl):S92-100.
PMID: 11052226
The MPTP monkey is a well-characterized animal model of parkinsonism and provides an exceptional tool for the study of dyskinesias induced by dopamine-like agents. Several such agents have been tested...
8.
Calon F, Morissette M, Goulet M, Grondin R, Blanchet P, Bedard P, et al.
Exp Neurol
. 2000 Apr;
163(1):191-9.
PMID: 10785458
Much evidence indicates that abnormal GABA neurotransmission may be implicated in the pathophysiology of Parkinson's disease (PD) and dopaminomimetic-induced dyskinesias (DID). In this study, autoradiography using (125)I-CGP 64213 was performed...
9.
Konitsiotis S, Blanchet P, Verhagen L, Lamers E, Chase T
Neurology
. 2000 Apr;
54(8):1589-95.
PMID: 10762498
Objective: To evaluate the contribution of amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) glutamate receptors to the pathogenesis of parkinsonian signs and levodopa-induced dyskinesias. Background: Motor fluctuations and dyskinesias reflect, in part, altered...
10.
Calon F, Grondin R, Morissette M, Goulet M, Blanchet P, Di Paolo T, et al.
Ann Neurol
. 2000 Apr;
47(4 Suppl 1):S70-8.
PMID: 10762134
A series of experiments were performed in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of parkinsonism for the purpose of understanding the mechanism of dopaminergic dyskinesias. Dyskinesias can be induced in this model...